Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.





Cost Of Sales Change Date
Addus HomeCare USD 251.77M 1.85M Mar/2026
Amarin USD 26.05M 1.41M Dec/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Option Care Health USD 1.1B 98.26M Mar/2026
Organigram Holdings CAD 56.93M 20.53M Dec/2025
Tilray USD 164.37M 8.41M Sep/2025